Pharmaids Pharmaceuticals Ltd — Others, 18-08-2025: AGM/EGM

Pharmaids Pharmaceuticals shareholders have approved two key proposals. They greenlit ongoing and new material related party transactions with Koye Lifesciences, totaling up to ₹20 Cr for FY2025-26, aiming to streamline business operations. Additionally, shareholders also cleared the divestment of the company's entire stake in Anugraha Chemicals, a material subsidiary, for ₹10.50 Cr. Both resolutions received overwhelming support, indicating strong investor confidence in these strategic moves. These decisions are set to impact the company's operational structure and financial position.